Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 6 matching records.
6 results — page 1 of 1
- Level DAnimal StudyEurope PMC
PAK4 phosphorylates cyclin-dependent kinase 2 to promote the G<sub>1</sub>/S transition during adipogenesis
Animal Study, published in Exp Mol Med (2025) — summary generated from the PubMed abstract.
- 2025
Exp Mol Med4 citations - Level DAnimal StudyEurope PMC
Chemical inhibitors of cyclin-dependent kinase (CDKi) improve pancreatic endocrine differentiation of iPS cells
Animal Study on Type 1 Diabetes, published in In Vitro Cell Dev Biol Anim (2023) — summary generated from the PubMed abstract.
- 2023
In Vitro Cell Dev Biol Anim3 citations - Level DAnimal StudyEurope PMC
The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
Animal Study on Type 2 Diabetes, published in Sci Rep (2021) — summary generated from the PubMed abstract.
- 2021
Sci Rep3 citations - Level DAnimal StudyPubMed
Differential expression of cyclin G2, cyclin-dependent kinase inhibitor 2C and peripheral myelin protein 22 genes during adipogenesis.
Animal Study on Systemic / IV, published in Animal (2014) — summary generated from the PubMed abstract.
- 2014
Animal11 citations - Level DLaboratory StudyPubMed
Cyclin-dependent kinase 4 signaling acts as a molecular switch between syngenic differentiation and neural transdifferentiation in human mesenchymal stem cells.
Laboratory Study on Neuroinflammation, published in Cell Cycle (2013) — summary generated from the PubMed abstract.
- 2013
Cell Cycle - Level DLaboratory StudyPubMed
The effects of cyclin-dependent kinase inhibitors on adipogenic differentiation of human mesenchymal stem cells.
Laboratory Study, published in Biochem Biophys Res Commun (2007) — summary generated from the PubMed abstract.
- 2007
Biochem Biophys Res Commun
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406